nodes	percent_of_prediction	percent_of_DWPC	metapath
Bosutinib—CYP3A4—Clindamycin—malaria	0.0271	0.214	CbGbCtD
Bosutinib—CYP3A4—Sulfadiazine—malaria	0.0156	0.123	CbGbCtD
Bosutinib—ABCB1—Quinine—malaria	0.0134	0.106	CbGbCtD
Bosutinib—CYP3A4—Artemether—malaria	0.0132	0.105	CbGbCtD
Bosutinib—CYP3A4—Proguanil—malaria	0.0125	0.0984	CbGbCtD
Bosutinib—CYP3A4—Doxycycline—malaria	0.0118	0.0933	CbGbCtD
Bosutinib—ABCB1—Quinidine—malaria	0.0118	0.093	CbGbCtD
Bosutinib—CYP3A4—Quinine—malaria	0.00802	0.0634	CbGbCtD
Bosutinib—CYP3A4—Quinidine—malaria	0.00705	0.0557	CbGbCtD
Bosutinib—CYP3A4—Dapsone—malaria	0.00608	0.0481	CbGbCtD
Bosutinib—Vandetanib—KDR—malaria	0.00449	1	CrCbGaD
Bosutinib—Rash maculo-papular—Clindamycin—malaria	0.00175	0.00738	CcSEcCtD
Bosutinib—Thrombocytopenia—Pyrimethamine—malaria	0.00175	0.00737	CcSEcCtD
Bosutinib—Respiratory failure—Quinidine barbiturate—malaria	0.00174	0.00732	CcSEcCtD
Bosutinib—Malnutrition—Proguanil—malaria	0.00171	0.00718	CcSEcCtD
Bosutinib—Decreased appetite—Pyrimethamine—malaria	0.00155	0.00654	CcSEcCtD
Bosutinib—Cough—Proguanil—malaria	0.00149	0.00627	CcSEcCtD
Bosutinib—Renal failure acute—Quinidine—malaria	0.00149	0.00627	CcSEcCtD
Bosutinib—Renal failure acute—Quinine—malaria	0.00149	0.00627	CcSEcCtD
Bosutinib—Renal impairment—Quinidine—malaria	0.00144	0.00608	CcSEcCtD
Bosutinib—Renal impairment—Quinine—malaria	0.00144	0.00608	CcSEcCtD
Bosutinib—Unspecified disorder of skin and subcutaneous tissue—Proguanil—malaria	0.00144	0.00607	CcSEcCtD
Bosutinib—Nervous system disorder—Proguanil—malaria	0.00137	0.00575	CcSEcCtD
Bosutinib—Skin disorder—Proguanil—malaria	0.00135	0.00569	CcSEcCtD
Bosutinib—Agranulocytosis—Sulfadiazine—malaria	0.00135	0.00569	CcSEcCtD
Bosutinib—Renal failure acute—Quinidine barbiturate—malaria	0.00134	0.00565	CcSEcCtD
Bosutinib—Renal impairment—Quinidine barbiturate—malaria	0.0013	0.00549	CcSEcCtD
Bosutinib—Hepatitis—Sulfadiazine—malaria	0.0013	0.00548	CcSEcCtD
Bosutinib—Nasopharyngitis—Dapsone—malaria	0.00129	0.00545	CcSEcCtD
Bosutinib—Abdominal pain upper—Clindamycin—malaria	0.00128	0.00539	CcSEcCtD
Bosutinib—Abdominal pain upper—Quinidine—malaria	0.00125	0.00528	CcSEcCtD
Bosutinib—Abdominal pain upper—Quinine—malaria	0.00125	0.00528	CcSEcCtD
Bosutinib—Influenza—Dapsone—malaria	0.00125	0.00527	CcSEcCtD
Bosutinib—Erythema multiforme—Sulfadiazine—malaria	0.00123	0.00518	CcSEcCtD
Bosutinib—Tinnitus—Sulfadiazine—malaria	0.00121	0.00511	CcSEcCtD
Bosutinib—Decreased appetite—Proguanil—malaria	0.00121	0.0051	CcSEcCtD
Bosutinib—Gastrointestinal disorder—Proguanil—malaria	0.0012	0.00506	CcSEcCtD
Bosutinib—Abdominal discomfort—Clindamycin—malaria	0.00116	0.00489	CcSEcCtD
Bosutinib—Gastrointestinal pain—Proguanil—malaria	0.00114	0.00479	CcSEcCtD
Bosutinib—Vomiting—Pyrimethamine—malaria	0.00114	0.00478	CcSEcCtD
Bosutinib—Abdominal pain upper—Quinidine barbiturate—malaria	0.00113	0.00477	CcSEcCtD
Bosutinib—Neutropenia—Clindamycin—malaria	0.00113	0.00477	CcSEcCtD
Bosutinib—Pancytopenia—Quinidine—malaria	0.00113	0.00475	CcSEcCtD
Bosutinib—Pancytopenia—Quinine—malaria	0.00113	0.00475	CcSEcCtD
Bosutinib—Upper respiratory tract infection—Clindamycin—malaria	0.00112	0.00474	CcSEcCtD
Bosutinib—Neutropenia—Quinidine—malaria	0.00111	0.00467	CcSEcCtD
Bosutinib—Neutropenia—Quinine—malaria	0.00111	0.00467	CcSEcCtD
Bosutinib—Abdominal pain—Proguanil—malaria	0.0011	0.00463	CcSEcCtD
Bosutinib—Body temperature increased—Proguanil—malaria	0.0011	0.00463	CcSEcCtD
Bosutinib—Renal failure—Quinidine—malaria	0.00104	0.00438	CcSEcCtD
Bosutinib—Renal failure—Quinine—malaria	0.00104	0.00438	CcSEcCtD
Bosutinib—Abdominal discomfort—Pentoxifylline—malaria	0.00103	0.00432	CcSEcCtD
Bosutinib—Pancytopenia—Quinidine barbiturate—malaria	0.00102	0.00428	CcSEcCtD
Bosutinib—Pancytopenia—Pentoxifylline—malaria	0.00102	0.00428	CcSEcCtD
Bosutinib—Leukopenia—Sulfadiazine—malaria	0.00101	0.00427	CcSEcCtD
Bosutinib—Agranulocytosis—Clindamycin—malaria	0.00101	0.00424	CcSEcCtD
Bosutinib—Neutropenia—Quinidine barbiturate—malaria	0.001	0.00422	CcSEcCtD
Bosutinib—Agranulocytosis—Quinidine—malaria	0.000988	0.00416	CcSEcCtD
Bosutinib—Agranulocytosis—Quinine—malaria	0.000988	0.00416	CcSEcCtD
Bosutinib—Arthralgia—Sulfadiazine—malaria	0.000964	0.00406	CcSEcCtD
Bosutinib—Infestation NOS—Pentoxifylline—malaria	0.000954	0.00402	CcSEcCtD
Bosutinib—Infestation—Pentoxifylline—malaria	0.000954	0.00402	CcSEcCtD
Bosutinib—Diarrhoea—Proguanil—malaria	0.000953	0.00401	CcSEcCtD
Bosutinib—Hepatitis—Quinidine—malaria	0.00095	0.004	CcSEcCtD
Bosutinib—Hepatitis—Quinine—malaria	0.00095	0.004	CcSEcCtD
Bosutinib—Renal failure—Quinidine barbiturate—malaria	0.000939	0.00395	CcSEcCtD
Bosutinib—Urinary tract disorder—Quinine—malaria	0.000939	0.00395	CcSEcCtD
Bosutinib—Urinary tract disorder—Quinidine—malaria	0.000939	0.00395	CcSEcCtD
Bosutinib—Tinnitus—Dapsone—malaria	0.000934	0.00393	CcSEcCtD
Bosutinib—Urethral disorder—Quinine—malaria	0.000932	0.00392	CcSEcCtD
Bosutinib—Urethral disorder—Quinidine—malaria	0.000932	0.00392	CcSEcCtD
Bosutinib—Anaphylactic shock—Sulfadiazine—malaria	0.000924	0.00389	CcSEcCtD
Bosutinib—Erythema multiforme—Clindamycin—malaria	0.000916	0.00386	CcSEcCtD
Bosutinib—Thrombocytopenia—Sulfadiazine—malaria	0.000905	0.00381	CcSEcCtD
Bosutinib—Hepatobiliary disease—Pentoxifylline—malaria	0.000902	0.0038	CcSEcCtD
Bosutinib—Erythema multiforme—Quinidine—malaria	0.000899	0.00378	CcSEcCtD
Bosutinib—Erythema multiforme—Quinine—malaria	0.000899	0.00378	CcSEcCtD
Bosutinib—Agranulocytosis—Quinidine barbiturate—malaria	0.000892	0.00375	CcSEcCtD
Bosutinib—Tinnitus—Quinine—malaria	0.000886	0.00373	CcSEcCtD
Bosutinib—Tinnitus—Quinidine—malaria	0.000886	0.00373	CcSEcCtD
Bosutinib—Vomiting—Proguanil—malaria	0.000885	0.00373	CcSEcCtD
Bosutinib—Cardiac disorder—Quinine—malaria	0.000882	0.00371	CcSEcCtD
Bosutinib—Cardiac disorder—Quinidine—malaria	0.000882	0.00371	CcSEcCtD
Bosutinib—Rash—Proguanil—malaria	0.000878	0.0037	CcSEcCtD
Bosutinib—Dermatitis—Proguanil—malaria	0.000877	0.00369	CcSEcCtD
Bosutinib—Headache—Proguanil—malaria	0.000872	0.00367	CcSEcCtD
Bosutinib—Immune system disorder—Quinidine—malaria	0.000858	0.00361	CcSEcCtD
Bosutinib—Immune system disorder—Quinine—malaria	0.000858	0.00361	CcSEcCtD
Bosutinib—Hepatitis—Quinidine barbiturate—malaria	0.000858	0.00361	CcSEcCtD
Bosutinib—Mediastinal disorder—Quinidine—malaria	0.000857	0.00361	CcSEcCtD
Bosutinib—Mediastinal disorder—Quinine—malaria	0.000857	0.00361	CcSEcCtD
Bosutinib—Hepatitis—Pentoxifylline—malaria	0.000856	0.0036	CcSEcCtD
Bosutinib—Urinary tract disorder—Quinidine barbiturate—malaria	0.000847	0.00357	CcSEcCtD
Bosutinib—Musculoskeletal discomfort—Sulfadiazine—malaria	0.000842	0.00355	CcSEcCtD
Bosutinib—Urethral disorder—Quinidine barbiturate—malaria	0.000841	0.00354	CcSEcCtD
Bosutinib—Malnutrition—Quinidine—malaria	0.000827	0.00348	CcSEcCtD
Bosutinib—Malnutrition—Quinine—malaria	0.000827	0.00348	CcSEcCtD
Bosutinib—Nausea—Proguanil—malaria	0.000827	0.00348	CcSEcCtD
Bosutinib—Dysgeusia—Clindamycin—malaria	0.000826	0.00348	CcSEcCtD
Bosutinib—Back pain—Clindamycin—malaria	0.000816	0.00343	CcSEcCtD
Bosutinib—Erythema multiforme—Quinidine barbiturate—malaria	0.000811	0.00341	CcSEcCtD
Bosutinib—Decreased appetite—Sulfadiazine—malaria	0.000804	0.00338	CcSEcCtD
Bosutinib—Tinnitus—Quinidine barbiturate—malaria	0.0008	0.00337	CcSEcCtD
Bosutinib—Gastrointestinal disorder—Sulfadiazine—malaria	0.000798	0.00336	CcSEcCtD
Bosutinib—Cardiac disorder—Quinidine barbiturate—malaria	0.000796	0.00335	CcSEcCtD
Bosutinib—Anaemia—Clindamycin—malaria	0.00078	0.00328	CcSEcCtD
Bosutinib—Immune system disorder—Quinidine barbiturate—malaria	0.000775	0.00326	CcSEcCtD
Bosutinib—Immune system disorder—Pentoxifylline—malaria	0.000773	0.00326	CcSEcCtD
Bosutinib—Mediastinal disorder—Quinidine barbiturate—malaria	0.000773	0.00325	CcSEcCtD
Bosutinib—Cough—Dapsone—malaria	0.000761	0.0032	CcSEcCtD
Bosutinib—Gastrointestinal pain—Sulfadiazine—malaria	0.000756	0.00318	CcSEcCtD
Bosutinib—Leukopenia—Clindamycin—malaria	0.000755	0.00318	CcSEcCtD
Bosutinib—Malnutrition—Quinidine barbiturate—malaria	0.000747	0.00314	CcSEcCtD
Bosutinib—Leukopenia—Quinidine—malaria	0.000741	0.00312	CcSEcCtD
Bosutinib—Leukopenia—Quinine—malaria	0.000741	0.00312	CcSEcCtD
Bosutinib—Urticaria—Sulfadiazine—malaria	0.000734	0.00309	CcSEcCtD
Bosutinib—Body temperature increased—Sulfadiazine—malaria	0.000731	0.00308	CcSEcCtD
Bosutinib—Abdominal pain—Sulfadiazine—malaria	0.000731	0.00308	CcSEcCtD
Bosutinib—Dysgeusia—Pentoxifylline—malaria	0.00073	0.00307	CcSEcCtD
Bosutinib—Back pain—Pentoxifylline—malaria	0.000721	0.00304	CcSEcCtD
Bosutinib—Discomfort—Clindamycin—malaria	0.000709	0.00299	CcSEcCtD
Bosutinib—Chest pain—Quinine—malaria	0.000704	0.00297	CcSEcCtD
Bosutinib—Chest pain—Quinidine—malaria	0.000704	0.00297	CcSEcCtD
Bosutinib—Myalgia—Quinidine—malaria	0.000704	0.00297	CcSEcCtD
Bosutinib—Myalgia—Quinine—malaria	0.000704	0.00297	CcSEcCtD
Bosutinib—Unspecified disorder of skin and subcutaneous tissue—Quinidine—malaria	0.0007	0.00295	CcSEcCtD
Bosutinib—Unspecified disorder of skin and subcutaneous tissue—Quinine—malaria	0.0007	0.00295	CcSEcCtD
Bosutinib—Ill-defined disorder—Pentoxifylline—malaria	0.000692	0.00291	CcSEcCtD
Bosutinib—Anaemia—Pentoxifylline—malaria	0.000689	0.0029	CcSEcCtD
Bosutinib—Anaphylactic shock—Clindamycin—malaria	0.000688	0.0029	CcSEcCtD
Bosutinib—Oedema—Quinine—malaria	0.000675	0.00284	CcSEcCtD
Bosutinib—Oedema—Quinidine—malaria	0.000675	0.00284	CcSEcCtD
Bosutinib—Thrombocytopenia—Clindamycin—malaria	0.000674	0.00284	CcSEcCtD
Bosutinib—Malaise—Pentoxifylline—malaria	0.000672	0.00283	CcSEcCtD
Bosutinib—Leukopenia—Quinidine barbiturate—malaria	0.000668	0.00281	CcSEcCtD
Bosutinib—Leukopenia—Pentoxifylline—malaria	0.000667	0.00281	CcSEcCtD
Bosutinib—Nervous system disorder—Quinidine—malaria	0.000662	0.00279	CcSEcCtD
Bosutinib—Nervous system disorder—Quinine—malaria	0.000662	0.00279	CcSEcCtD
Bosutinib—Thrombocytopenia—Quinine—malaria	0.000661	0.00278	CcSEcCtD
Bosutinib—Thrombocytopenia—Quinidine—malaria	0.000661	0.00278	CcSEcCtD
Bosutinib—Skin disorder—Quinidine—malaria	0.000656	0.00276	CcSEcCtD
Bosutinib—Skin disorder—Quinine—malaria	0.000656	0.00276	CcSEcCtD
Bosutinib—Pruritus—Sulfadiazine—malaria	0.000654	0.00275	CcSEcCtD
Bosutinib—Arthralgia—Quinidine barbiturate—malaria	0.000636	0.00268	CcSEcCtD
Bosutinib—Chest pain—Quinidine barbiturate—malaria	0.000636	0.00268	CcSEcCtD
Bosutinib—Myalgia—Quinidine barbiturate—malaria	0.000636	0.00268	CcSEcCtD
Bosutinib—Myalgia—Pentoxifylline—malaria	0.000635	0.00267	CcSEcCtD
Bosutinib—Chest pain—Pentoxifylline—malaria	0.000635	0.00267	CcSEcCtD
Bosutinib—Diarrhoea—Sulfadiazine—malaria	0.000632	0.00266	CcSEcCtD
Bosutinib—Unspecified disorder of skin and subcutaneous tissue—Quinidine barbiturate—malaria	0.000631	0.00266	CcSEcCtD
Bosutinib—Unspecified disorder of skin and subcutaneous tissue—Pentoxifylline—malaria	0.00063	0.00265	CcSEcCtD
Bosutinib—Discomfort—Pentoxifylline—malaria	0.000627	0.00264	CcSEcCtD
Bosutinib—Musculoskeletal discomfort—Quinine—malaria	0.000615	0.00259	CcSEcCtD
Bosutinib—Musculoskeletal discomfort—Quinidine—malaria	0.000615	0.00259	CcSEcCtD
Bosutinib—Dyspnoea—Clindamycin—malaria	0.000614	0.00258	CcSEcCtD
Bosutinib—Oedema—Quinidine barbiturate—malaria	0.000609	0.00257	CcSEcCtD
Bosutinib—Anaphylactic shock—Pentoxifylline—malaria	0.000608	0.00256	CcSEcCtD
Bosutinib—Oedema—Pentoxifylline—malaria	0.000608	0.00256	CcSEcCtD
Bosutinib—Infection—Pentoxifylline—malaria	0.000604	0.00254	CcSEcCtD
Bosutinib—Dyspnoea—Quinidine—malaria	0.000602	0.00253	CcSEcCtD
Bosutinib—Dyspnoea—Quinine—malaria	0.000602	0.00253	CcSEcCtD
Bosutinib—Nervous system disorder—Quinidine barbiturate—malaria	0.000598	0.00252	CcSEcCtD
Bosutinib—Thrombocytopenia—Quinidine barbiturate—malaria	0.000597	0.00251	CcSEcCtD
Bosutinib—Thrombocytopenia—Pentoxifylline—malaria	0.000596	0.00251	CcSEcCtD
Bosutinib—Gastrointestinal disorder—Clindamycin—malaria	0.000594	0.0025	CcSEcCtD
Bosutinib—Fatigue—Clindamycin—malaria	0.000593	0.0025	CcSEcCtD
Bosutinib—Skin disorder—Quinidine barbiturate—malaria	0.000592	0.00249	CcSEcCtD
Bosutinib—Skin disorder—Pentoxifylline—malaria	0.000591	0.00249	CcSEcCtD
Bosutinib—Pain—Clindamycin—malaria	0.000589	0.00248	CcSEcCtD
Bosutinib—Vomiting—Sulfadiazine—malaria	0.000588	0.00247	CcSEcCtD
Bosutinib—Decreased appetite—Quinidine—malaria	0.000587	0.00247	CcSEcCtD
Bosutinib—Decreased appetite—Quinine—malaria	0.000587	0.00247	CcSEcCtD
Bosutinib—Gastrointestinal disorder—Quinine—malaria	0.000583	0.00245	CcSEcCtD
Bosutinib—Gastrointestinal disorder—Quinidine—malaria	0.000583	0.00245	CcSEcCtD
Bosutinib—Rash—Sulfadiazine—malaria	0.000583	0.00245	CcSEcCtD
Bosutinib—Dermatitis—Sulfadiazine—malaria	0.000582	0.00245	CcSEcCtD
Bosutinib—Gastrointestinal pain—Dapsone—malaria	0.000582	0.00245	CcSEcCtD
Bosutinib—SRMS—brain—malaria	0.00058	0.00183	CbGeAlD
Bosutinib—CAMK1D—liver—malaria	0.000579	0.00183	CbGeAlD
Bosutinib—Headache—Sulfadiazine—malaria	0.000579	0.00244	CcSEcCtD
Bosutinib—HCK—blood—malaria	0.000579	0.00183	CbGeAlD
Bosutinib—CLK1—blood—malaria	0.000579	0.00183	CbGeAlD
Bosutinib—PTK2B—digestive system—malaria	0.000576	0.00182	CbGeAlD
Bosutinib—ABL2—blood—malaria	0.000575	0.00182	CbGeAlD
Bosutinib—STK24—liver—malaria	0.000573	0.00181	CbGeAlD
Bosutinib—MAP2K1—bone marrow—malaria	0.000571	0.00181	CbGeAlD
Bosutinib—EPHB4—kidney—malaria	0.000569	0.0018	CbGeAlD
Bosutinib—MAP2K5—saliva-secreting gland—malaria	0.000569	0.0018	CbGeAlD
Bosutinib—FES—brain—malaria	0.000568	0.0018	CbGeAlD
Bosutinib—VRK2—brain—malaria	0.000568	0.0018	CbGeAlD
Bosutinib—EPHA8—brain—malaria	0.000568	0.0018	CbGeAlD
Bosutinib—CAMK2G—blood—malaria	0.000568	0.0018	CbGeAlD
Bosutinib—BMP2K—blood—malaria	0.000568	0.0018	CbGeAlD
Bosutinib—CSK—bone marrow—malaria	0.000567	0.00179	CbGeAlD
Bosutinib—CSNK1E—digestive system—malaria	0.000567	0.00179	CbGeAlD
Bosutinib—CSNK1A1—bone marrow—malaria	0.000564	0.00178	CbGeAlD
Bosutinib—LRRK2—blood—malaria	0.000563	0.00178	CbGeAlD
Bosutinib—Gastrointestinal pain—Clindamycin—malaria	0.000563	0.00237	CcSEcCtD
Bosutinib—Body temperature increased—Dapsone—malaria	0.000563	0.00237	CcSEcCtD
Bosutinib—Abdominal pain—Dapsone—malaria	0.000563	0.00237	CcSEcCtD
Bosutinib—HCK—bone marrow—malaria	0.00056	0.00177	CbGeAlD
Bosutinib—CLK1—bone marrow—malaria	0.00056	0.00177	CbGeAlD
Bosutinib—SYK—brain—malaria	0.000557	0.00176	CbGeAlD
Bosutinib—TNIK—brain—malaria	0.000557	0.00176	CbGeAlD
Bosutinib—FYN—kidney—malaria	0.000557	0.00176	CbGeAlD
Bosutinib—Feeling abnormal—Quinine—malaria	0.000556	0.00234	CcSEcCtD
Bosutinib—Feeling abnormal—Quinidine—malaria	0.000556	0.00234	CcSEcCtD
Bosutinib—Musculoskeletal discomfort—Quinidine barbiturate—malaria	0.000555	0.00234	CcSEcCtD
Bosutinib—Musculoskeletal discomfort—Pentoxifylline—malaria	0.000554	0.00233	CcSEcCtD
Bosutinib—FER—liver—malaria	0.000554	0.00175	CbGeAlD
Bosutinib—CDK2—brain—malaria	0.000552	0.00175	CbGeAlD
Bosutinib—Gastrointestinal pain—Quinine—malaria	0.000552	0.00232	CcSEcCtD
Bosutinib—Gastrointestinal pain—Quinidine—malaria	0.000552	0.00232	CcSEcCtD
Bosutinib—LYN—liver—malaria	0.000551	0.00174	CbGeAlD
Bosutinib—BMP2K—bone marrow—malaria	0.00055	0.00174	CbGeAlD
Bosutinib—CAMK2G—bone marrow—malaria	0.00055	0.00174	CbGeAlD
Bosutinib—Nausea—Sulfadiazine—malaria	0.000549	0.00231	CcSEcCtD
Bosutinib—PTK2B—blood—malaria	0.000549	0.00173	CbGeAlD
Bosutinib—STK26—brain—malaria	0.000547	0.00173	CbGeAlD
Bosutinib—ERBB3—digestive system—malaria	0.000547	0.00173	CbGeAlD
Bosutinib—Urticaria—Clindamycin—malaria	0.000547	0.0023	CcSEcCtD
Bosutinib—ULK3—digestive system—malaria	0.000546	0.00172	CbGeAlD
Bosutinib—MAP2K2—digestive system—malaria	0.000546	0.00172	CbGeAlD
Bosutinib—LRRK2—bone marrow—malaria	0.000545	0.00172	CbGeAlD
Bosutinib—Body temperature increased—Clindamycin—malaria	0.000544	0.00229	CcSEcCtD
Bosutinib—Abdominal pain—Clindamycin—malaria	0.000544	0.00229	CcSEcCtD
Bosutinib—Dyspnoea—Quinidine barbiturate—malaria	0.000543	0.00229	CcSEcCtD
Bosutinib—Dyspnoea—Pentoxifylline—malaria	0.000542	0.00228	CcSEcCtD
Bosutinib—BTK—liver—malaria	0.00054	0.00171	CbGeAlD
Bosutinib—CSNK1E—blood—malaria	0.00054	0.00171	CbGeAlD
Bosutinib—Urticaria—Quinine—malaria	0.000536	0.00226	CcSEcCtD
Bosutinib—Urticaria—Quinidine—malaria	0.000536	0.00226	CcSEcCtD
Bosutinib—Body temperature increased—Quinidine—malaria	0.000534	0.00225	CcSEcCtD
Bosutinib—Abdominal pain—Quinidine—malaria	0.000534	0.00225	CcSEcCtD
Bosutinib—Abdominal pain—Quinine—malaria	0.000534	0.00225	CcSEcCtD
Bosutinib—Body temperature increased—Quinine—malaria	0.000534	0.00225	CcSEcCtD
Bosutinib—TNK2—liver—malaria	0.000532	0.00168	CbGeAlD
Bosutinib—SIK1—blood—malaria	0.000532	0.00168	CbGeAlD
Bosutinib—IRAK4—blood—malaria	0.000532	0.00168	CbGeAlD
Bosutinib—PTK2B—bone marrow—malaria	0.000531	0.00168	CbGeAlD
Bosutinib—TBK1—digestive system—malaria	0.00053	0.00168	CbGeAlD
Bosutinib—PTK2—digestive system—malaria	0.00053	0.00168	CbGeAlD
Bosutinib—CSF1R—hematopoietic system—malaria	0.00053	0.00167	CbGeAlD
Bosutinib—Decreased appetite—Quinidine barbiturate—malaria	0.00053	0.00223	CcSEcCtD
Bosutinib—Decreased appetite—Pentoxifylline—malaria	0.000529	0.00223	CcSEcCtD
Bosutinib—CHEK2—brain—malaria	0.000528	0.00167	CbGeAlD
Bosutinib—EPHA4—blood—malaria	0.000526	0.00166	CbGeAlD
Bosutinib—Gastrointestinal disorder—Quinidine barbiturate—malaria	0.000526	0.00222	CcSEcCtD
Bosutinib—MAP4K2—liver—malaria	0.000525	0.00166	CbGeAlD
Bosutinib—WEE1—brain—malaria	0.000524	0.00166	CbGeAlD
Bosutinib—DMPK—brain—malaria	0.000524	0.00166	CbGeAlD
Bosutinib—Pain—Quinidine barbiturate—malaria	0.000521	0.00219	CcSEcCtD
Bosutinib—MAP2K2—blood—malaria	0.00052	0.00164	CbGeAlD
Bosutinib—ULK3—blood—malaria	0.00052	0.00164	CbGeAlD
Bosutinib—STK3—liver—malaria	0.000518	0.00164	CbGeAlD
Bosutinib—MAP3K2—blood—malaria	0.000516	0.00163	CbGeAlD
Bosutinib—IRAK4—bone marrow—malaria	0.000514	0.00163	CbGeAlD
Bosutinib—SIK1—bone marrow—malaria	0.000514	0.00163	CbGeAlD
Bosutinib—ROCK1—liver—malaria	0.000511	0.00162	CbGeAlD
Bosutinib—MAP3K7—blood—malaria	0.000511	0.00162	CbGeAlD
Bosutinib—RPS6KB1—digestive system—malaria	0.00051	0.00161	CbGeAlD
Bosutinib—FGR—digestive system—malaria	0.000507	0.0016	CbGeAlD
Bosutinib—TBK1—blood—malaria	0.000505	0.0016	CbGeAlD
Bosutinib—PTK2—blood—malaria	0.000505	0.0016	CbGeAlD
Bosutinib—YES1—kidney—malaria	0.000503	0.00159	CbGeAlD
Bosutinib—ULK3—bone marrow—malaria	0.000503	0.00159	CbGeAlD
Bosutinib—MAP2K2—bone marrow—malaria	0.000503	0.00159	CbGeAlD
Bosutinib—Feeling abnormal—Quinidine barbiturate—malaria	0.000502	0.00211	CcSEcCtD
Bosutinib—Feeling abnormal—Pentoxifylline—malaria	0.000501	0.00211	CcSEcCtD
Bosutinib—STK25—brain—malaria	0.0005	0.00158	CbGeAlD
Bosutinib—MAP3K2—bone marrow—malaria	0.000499	0.00158	CbGeAlD
Bosutinib—STK10—kidney—malaria	0.000498	0.00157	CbGeAlD
Bosutinib—Gastrointestinal pain—Quinidine barbiturate—malaria	0.000498	0.0021	CcSEcCtD
Bosutinib—Gastrointestinal pain—Pentoxifylline—malaria	0.000497	0.00209	CcSEcCtD
Bosutinib—EPHA3—brain—malaria	0.000497	0.00157	CbGeAlD
Bosutinib—BMPR2—liver—malaria	0.000497	0.00157	CbGeAlD
Bosutinib—TAOK3—kidney—malaria	0.000496	0.00157	CbGeAlD
Bosutinib—IRAK1—blood—malaria	0.000495	0.00157	CbGeAlD
Bosutinib—MAP3K7—bone marrow—malaria	0.000495	0.00156	CbGeAlD
Bosutinib—Asthenia—Clindamycin—malaria	0.000494	0.00208	CcSEcCtD
Bosutinib—STK36—liver—malaria	0.000493	0.00156	CbGeAlD
Bosutinib—PDGFRB—saliva-secreting gland—malaria	0.000492	0.00156	CbGeAlD
Bosutinib—TBK1—bone marrow—malaria	0.000489	0.00155	CbGeAlD
Bosutinib—Pruritus—Clindamycin—malaria	0.000487	0.00205	CcSEcCtD
Bosutinib—MERTK—liver—malaria	0.000487	0.00154	CbGeAlD
Bosutinib—PLK2—brain—malaria	0.000487	0.00154	CbGeAlD
Bosutinib—RPS6KB1—blood—malaria	0.000486	0.00154	CbGeAlD
Bosutinib—Asthenia—Quinine—malaria	0.000484	0.00204	CcSEcCtD
Bosutinib—Asthenia—Quinidine—malaria	0.000484	0.00204	CcSEcCtD
Bosutinib—Urticaria—Quinidine barbiturate—malaria	0.000484	0.00204	CcSEcCtD
Bosutinib—SRC—kidney—malaria	0.000484	0.00153	CbGeAlD
Bosutinib—SIK3—brain—malaria	0.000483	0.00153	CbGeAlD
Bosutinib—Urticaria—Pentoxifylline—malaria	0.000483	0.00203	CcSEcCtD
Bosutinib—FGR—blood—malaria	0.000483	0.00153	CbGeAlD
Bosutinib—LCK—blood—malaria	0.000483	0.00153	CbGeAlD
Bosutinib—EPHB4—digestive system—malaria	0.000483	0.00153	CbGeAlD
Bosutinib—Abdominal pain—Quinidine barbiturate—malaria	0.000482	0.00203	CcSEcCtD
Bosutinib—Body temperature increased—Quinidine barbiturate—malaria	0.000482	0.00203	CcSEcCtD
Bosutinib—Abdominal pain—Pentoxifylline—malaria	0.000481	0.00202	CcSEcCtD
Bosutinib—Body temperature increased—Pentoxifylline—malaria	0.000481	0.00202	CcSEcCtD
Bosutinib—IRAK1—bone marrow—malaria	0.000479	0.00151	CbGeAlD
Bosutinib—MAP4K4—liver—malaria	0.000478	0.00151	CbGeAlD
Bosutinib—Pruritus—Quinine—malaria	0.000478	0.00201	CcSEcCtD
Bosutinib—Pruritus—Quinidine—malaria	0.000478	0.00201	CcSEcCtD
Bosutinib—NUAK2—liver—malaria	0.000475	0.0015	CbGeAlD
Bosutinib—BCR—liver—malaria	0.000475	0.0015	CbGeAlD
Bosutinib—EPHA2—digestive system—malaria	0.000474	0.0015	CbGeAlD
Bosutinib—FYN—digestive system—malaria	0.000473	0.00149	CbGeAlD
Bosutinib—MAP3K12—liver—malaria	0.000471	0.00149	CbGeAlD
Bosutinib—Diarrhoea—Clindamycin—malaria	0.000471	0.00198	CcSEcCtD
Bosutinib—RPS6KB1—bone marrow—malaria	0.00047	0.00149	CbGeAlD
Bosutinib—PDGFRB—hematopoietic system—malaria	0.00047	0.00149	CbGeAlD
Bosutinib—FGR—bone marrow—malaria	0.000468	0.00148	CbGeAlD
Bosutinib—LCK—bone marrow—malaria	0.000468	0.00148	CbGeAlD
Bosutinib—STK4—brain—malaria	0.000465	0.00147	CbGeAlD
Bosutinib—SLK—blood—malaria	0.000463	0.00146	CbGeAlD
Bosutinib—Diarrhoea—Quinidine—malaria	0.000462	0.00195	CcSEcCtD
Bosutinib—Diarrhoea—Quinine—malaria	0.000462	0.00195	CcSEcCtD
Bosutinib—MAP2K1—liver—malaria	0.000462	0.00146	CbGeAlD
Bosutinib—STK35—liver—malaria	0.000462	0.00146	CbGeAlD
Bosutinib—EPHB4—blood—malaria	0.00046	0.00145	CbGeAlD
Bosutinib—CAMK1D—brain—malaria	0.00046	0.00145	CbGeAlD
Bosutinib—CSK—liver—malaria	0.000459	0.00145	CbGeAlD
Bosutinib—CSNK1A1—liver—malaria	0.000456	0.00144	CbGeAlD
Bosutinib—Dizziness—Clindamycin—malaria	0.000455	0.00192	CcSEcCtD
Bosutinib—STK24—brain—malaria	0.000454	0.00144	CbGeAlD
Bosutinib—HCK—liver—malaria	0.000453	0.00143	CbGeAlD
Bosutinib—CLK1—liver—malaria	0.000453	0.00143	CbGeAlD
Bosutinib—Vomiting—Dapsone—malaria	0.000452	0.0019	CcSEcCtD
Bosutinib—EPHA2—blood—malaria	0.000451	0.00143	CbGeAlD
Bosutinib—FYN—blood—malaria	0.00045	0.00142	CbGeAlD
Bosutinib—ABL2—liver—malaria	0.00045	0.00142	CbGeAlD
Bosutinib—SLK—bone marrow—malaria	0.000448	0.00142	CbGeAlD
Bosutinib—Dizziness—Quinidine—malaria	0.000447	0.00188	CcSEcCtD
Bosutinib—Dizziness—Quinine—malaria	0.000447	0.00188	CcSEcCtD
Bosutinib—Headache—Dapsone—malaria	0.000446	0.00188	CcSEcCtD
Bosutinib—EPHB4—bone marrow—malaria	0.000445	0.00141	CbGeAlD
Bosutinib—BMP2K—liver—malaria	0.000444	0.0014	CbGeAlD
Bosutinib—CAMK2G—liver—malaria	0.000444	0.0014	CbGeAlD
Bosutinib—LRRK2—liver—malaria	0.00044	0.00139	CbGeAlD
Bosutinib—MAP3K3—blood—malaria	0.00044	0.00139	CbGeAlD
Bosutinib—MAP4K5—blood—malaria	0.00044	0.00139	CbGeAlD
Bosutinib—FER—brain—malaria	0.00044	0.00139	CbGeAlD
Bosutinib—EPHA5—brain—malaria	0.00044	0.00139	CbGeAlD
Bosutinib—TYRO3—brain—malaria	0.00044	0.00139	CbGeAlD
Bosutinib—ALK—brain—malaria	0.00044	0.00139	CbGeAlD
Bosutinib—EGFR—liver—malaria	0.000439	0.00139	CbGeAlD
Bosutinib—ABL1—saliva-secreting gland—malaria	0.000439	0.00139	CbGeAlD
Bosutinib—Vomiting—Clindamycin—malaria	0.000438	0.00184	CcSEcCtD
Bosutinib—LYN—brain—malaria	0.000437	0.00138	CbGeAlD
Bosutinib—Asthenia—Quinidine barbiturate—malaria	0.000437	0.00184	CcSEcCtD
Bosutinib—Asthenia—Pentoxifylline—malaria	0.000436	0.00184	CcSEcCtD
Bosutinib—FYN—bone marrow—malaria	0.000436	0.00138	CbGeAlD
Bosutinib—Rash—Clindamycin—malaria	0.000434	0.00183	CcSEcCtD
Bosutinib—Dermatitis—Clindamycin—malaria	0.000434	0.00183	CcSEcCtD
Bosutinib—Headache—Clindamycin—malaria	0.000431	0.00182	CcSEcCtD
Bosutinib—Pruritus—Quinidine barbiturate—malaria	0.000431	0.00182	CcSEcCtD
Bosutinib—MAP4K1—brain—malaria	0.000431	0.00136	CbGeAlD
Bosutinib—MAP3K19—brain—malaria	0.000431	0.00136	CbGeAlD
Bosutinib—Pruritus—Pentoxifylline—malaria	0.00043	0.00181	CcSEcCtD
Bosutinib—Vomiting—Quinine—malaria	0.000429	0.00181	CcSEcCtD
Bosutinib—Vomiting—Quinidine—malaria	0.000429	0.00181	CcSEcCtD
Bosutinib—PTK2B—liver—malaria	0.000429	0.00136	CbGeAlD
Bosutinib—BTK—brain—malaria	0.000429	0.00135	CbGeAlD
Bosutinib—YES1—digestive system—malaria	0.000427	0.00135	CbGeAlD
Bosutinib—MAP4K5—bone marrow—malaria	0.000426	0.00135	CbGeAlD
Bosutinib—MAP3K3—bone marrow—malaria	0.000426	0.00135	CbGeAlD
Bosutinib—Rash—Quinine—malaria	0.000426	0.00179	CcSEcCtD
Bosutinib—Rash—Quinidine—malaria	0.000426	0.00179	CcSEcCtD
Bosutinib—Dermatitis—Quinine—malaria	0.000425	0.00179	CcSEcCtD
Bosutinib—Dermatitis—Quinidine—malaria	0.000425	0.00179	CcSEcCtD
Bosutinib—Headache—Quinine—malaria	0.000423	0.00178	CcSEcCtD
Bosutinib—Headache—Quinidine—malaria	0.000423	0.00178	CcSEcCtD
Bosutinib—STK10—digestive system—malaria	0.000423	0.00134	CbGeAlD
Bosutinib—Nausea—Dapsone—malaria	0.000423	0.00178	CcSEcCtD
Bosutinib—TNK2—brain—malaria	0.000422	0.00134	CbGeAlD
Bosutinib—CSNK1E—liver—malaria	0.000422	0.00133	CbGeAlD
Bosutinib—TAOK3—digestive system—malaria	0.000421	0.00133	CbGeAlD
Bosutinib—ABL1—hematopoietic system—malaria	0.000419	0.00132	CbGeAlD
Bosutinib—Diarrhoea—Quinidine barbiturate—malaria	0.000417	0.00176	CcSEcCtD
Bosutinib—MAP4K2—brain—malaria	0.000417	0.00132	CbGeAlD
Bosutinib—Diarrhoea—Pentoxifylline—malaria	0.000416	0.00175	CcSEcCtD
Bosutinib—SIK1—liver—malaria	0.000416	0.00131	CbGeAlD
Bosutinib—IRAK4—liver—malaria	0.000416	0.00131	CbGeAlD
Bosutinib—ERBB4—brain—malaria	0.000411	0.0013	CbGeAlD
Bosutinib—STK3—brain—malaria	0.000411	0.0013	CbGeAlD
Bosutinib—SRC—digestive system—malaria	0.00041	0.0013	CbGeAlD
Bosutinib—Nausea—Clindamycin—malaria	0.000409	0.00172	CcSEcCtD
Bosutinib—ERBB3—liver—malaria	0.000407	0.00129	CbGeAlD
Bosutinib—YES1—blood—malaria	0.000406	0.00128	CbGeAlD
Bosutinib—ULK3—liver—malaria	0.000406	0.00128	CbGeAlD
Bosutinib—MAP2K2—liver—malaria	0.000406	0.00128	CbGeAlD
Bosutinib—ROCK1—brain—malaria	0.000406	0.00128	CbGeAlD
Bosutinib—MAP3K2—liver—malaria	0.000404	0.00128	CbGeAlD
Bosutinib—Dizziness—Quinidine barbiturate—malaria	0.000403	0.0017	CcSEcCtD
Bosutinib—STK10—blood—malaria	0.000403	0.00127	CbGeAlD
Bosutinib—Dizziness—Pentoxifylline—malaria	0.000402	0.00169	CcSEcCtD
Bosutinib—TAOK3—blood—malaria	0.000401	0.00127	CbGeAlD
Bosutinib—Nausea—Quinidine—malaria	0.000401	0.00169	CcSEcCtD
Bosutinib—Nausea—Quinine—malaria	0.000401	0.00169	CcSEcCtD
Bosutinib—MAP3K7—liver—malaria	0.0004	0.00126	CbGeAlD
Bosutinib—TBK1—liver—malaria	0.000395	0.00125	CbGeAlD
Bosutinib—PTK2—liver—malaria	0.000395	0.00125	CbGeAlD
Bosutinib—BMPR2—brain—malaria	0.000394	0.00125	CbGeAlD
Bosutinib—YES1—bone marrow—malaria	0.000393	0.00124	CbGeAlD
Bosutinib—SRC—blood—malaria	0.000391	0.00124	CbGeAlD
Bosutinib—STK36—brain—malaria	0.000391	0.00124	CbGeAlD
Bosutinib—EPHB3—brain—malaria	0.000391	0.00124	CbGeAlD
Bosutinib—STK10—bone marrow—malaria	0.00039	0.00123	CbGeAlD
Bosutinib—TAOK3—bone marrow—malaria	0.000388	0.00123	CbGeAlD
Bosutinib—Vomiting—Quinidine barbiturate—malaria	0.000387	0.00163	CcSEcCtD
Bosutinib—IRAK1—liver—malaria	0.000387	0.00122	CbGeAlD
Bosutinib—Vomiting—Pentoxifylline—malaria	0.000387	0.00163	CcSEcCtD
Bosutinib—MERTK—brain—malaria	0.000386	0.00122	CbGeAlD
Bosutinib—PDGFRB—kidney—malaria	0.000385	0.00122	CbGeAlD
Bosutinib—Rash—Quinidine barbiturate—malaria	0.000384	0.00162	CcSEcCtD
Bosutinib—Dermatitis—Quinidine barbiturate—malaria	0.000384	0.00162	CcSEcCtD
Bosutinib—Rash—Pentoxifylline—malaria	0.000384	0.00161	CcSEcCtD
Bosutinib—Dermatitis—Pentoxifylline—malaria	0.000383	0.00161	CcSEcCtD
Bosutinib—Headache—Quinidine barbiturate—malaria	0.000382	0.00161	CcSEcCtD
Bosutinib—Headache—Pentoxifylline—malaria	0.000381	0.0016	CcSEcCtD
Bosutinib—RPS6KB1—liver—malaria	0.00038	0.0012	CbGeAlD
Bosutinib—MAP4K4—brain—malaria	0.000379	0.0012	CbGeAlD
Bosutinib—LCK—liver—malaria	0.000378	0.00119	CbGeAlD
Bosutinib—FGR—liver—malaria	0.000378	0.00119	CbGeAlD
Bosutinib—BCR—brain—malaria	0.000377	0.00119	CbGeAlD
Bosutinib—NUAK2—brain—malaria	0.000377	0.00119	CbGeAlD
Bosutinib—AXL—liver—malaria	0.000376	0.00119	CbGeAlD
Bosutinib—MAP3K12—brain—malaria	0.000374	0.00118	CbGeAlD
Bosutinib—CSF1R—digestive system—malaria	0.000369	0.00116	CbGeAlD
Bosutinib—MAP2K1—brain—malaria	0.000366	0.00116	CbGeAlD
Bosutinib—STK35—brain—malaria	0.000366	0.00116	CbGeAlD
Bosutinib—CSK—brain—malaria	0.000364	0.00115	CbGeAlD
Bosutinib—SLK—liver—malaria	0.000362	0.00114	CbGeAlD
Bosutinib—Nausea—Quinidine barbiturate—malaria	0.000362	0.00152	CcSEcCtD
Bosutinib—CSNK1A1—brain—malaria	0.000362	0.00114	CbGeAlD
Bosutinib—Nausea—Pentoxifylline—malaria	0.000361	0.00152	CcSEcCtD
Bosutinib—MAP2K5—blood—malaria	0.00036	0.00114	CbGeAlD
Bosutinib—EPHB4—liver—malaria	0.00036	0.00114	CbGeAlD
Bosutinib—HCK—brain—malaria	0.000359	0.00114	CbGeAlD
Bosutinib—CLK1—brain—malaria	0.000359	0.00114	CbGeAlD
Bosutinib—ABL2—brain—malaria	0.000357	0.00113	CbGeAlD
Bosutinib—EPHA2—liver—malaria	0.000353	0.00111	CbGeAlD
Bosutinib—CAMK2G—brain—malaria	0.000353	0.00111	CbGeAlD
Bosutinib—BMP2K—brain—malaria	0.000353	0.00111	CbGeAlD
Bosutinib—FYN—liver—malaria	0.000352	0.00111	CbGeAlD
Bosutinib—CSF1R—blood—malaria	0.000351	0.00111	CbGeAlD
Bosutinib—LRRK2—brain—malaria	0.000349	0.0011	CbGeAlD
Bosutinib—EGFR—brain—malaria	0.000348	0.0011	CbGeAlD
Bosutinib—MAP4K5—liver—malaria	0.000344	0.00109	CbGeAlD
Bosutinib—MAP3K3—liver—malaria	0.000344	0.00109	CbGeAlD
Bosutinib—ABL1—kidney—malaria	0.000343	0.00108	CbGeAlD
Bosutinib—PTK2B—brain—malaria	0.000341	0.00108	CbGeAlD
Bosutinib—CSF1R—bone marrow—malaria	0.00034	0.00107	CbGeAlD
Bosutinib—CSNK1E—brain—malaria	0.000335	0.00106	CbGeAlD
Bosutinib—CYP3A4—blood plasma—malaria	0.000333	0.00105	CbGeAlD
Bosutinib—IRAK4—brain—malaria	0.00033	0.00104	CbGeAlD
Bosutinib—SIK1—brain—malaria	0.00033	0.00104	CbGeAlD
Bosutinib—PDGFRB—digestive system—malaria	0.000327	0.00103	CbGeAlD
Bosutinib—EPHA4—brain—malaria	0.000326	0.00103	CbGeAlD
Bosutinib—ERBB3—brain—malaria	0.000323	0.00102	CbGeAlD
Bosutinib—MAP2K2—brain—malaria	0.000322	0.00102	CbGeAlD
Bosutinib—ULK3—brain—malaria	0.000322	0.00102	CbGeAlD
Bosutinib—MAP3K2—brain—malaria	0.00032	0.00101	CbGeAlD
Bosutinib—YES1—liver—malaria	0.000318	0.001	CbGeAlD
Bosutinib—MAP3K7—brain—malaria	0.000317	0.001	CbGeAlD
Bosutinib—STK10—liver—malaria	0.000315	0.000995	CbGeAlD
Bosutinib—TAOK3—liver—malaria	0.000314	0.000992	CbGeAlD
Bosutinib—TBK1—brain—malaria	0.000314	0.000991	CbGeAlD
Bosutinib—PTK2—brain—malaria	0.000314	0.000991	CbGeAlD
Bosutinib—PDGFRB—blood—malaria	0.000311	0.000984	CbGeAlD
Bosutinib—IRAK1—brain—malaria	0.000307	0.000971	CbGeAlD
Bosutinib—SRC—liver—malaria	0.000306	0.000966	CbGeAlD
Bosutinib—RPS6KB1—brain—malaria	0.000302	0.000953	CbGeAlD
Bosutinib—PDGFRB—bone marrow—malaria	0.000301	0.000952	CbGeAlD
Bosutinib—FGR—brain—malaria	0.0003	0.000947	CbGeAlD
Bosutinib—AXL—brain—malaria	0.000299	0.000944	CbGeAlD
Bosutinib—ABL1—digestive system—malaria	0.000291	0.000921	CbGeAlD
Bosutinib—SLK—brain—malaria	0.000287	0.000908	CbGeAlD
Bosutinib—EPHB4—brain—malaria	0.000285	0.000902	CbGeAlD
Bosutinib—MAP2K5—liver—malaria	0.000281	0.000889	CbGeAlD
Bosutinib—EPHA2—brain—malaria	0.00028	0.000885	CbGeAlD
Bosutinib—FYN—brain—malaria	0.000279	0.000883	CbGeAlD
Bosutinib—ABL1—blood—malaria	0.000278	0.000877	CbGeAlD
Bosutinib—CSF1R—liver—malaria	0.000275	0.000868	CbGeAlD
Bosutinib—MAP4K5—brain—malaria	0.000273	0.000863	CbGeAlD
Bosutinib—MAP3K3—brain—malaria	0.000273	0.000863	CbGeAlD
Bosutinib—ABL1—bone marrow—malaria	0.000269	0.000849	CbGeAlD
Bosutinib—YES1—brain—malaria	0.000252	0.000797	CbGeAlD
Bosutinib—STK10—brain—malaria	0.00025	0.00079	CbGeAlD
Bosutinib—TAOK3—brain—malaria	0.000249	0.000787	CbGeAlD
Bosutinib—PDGFRB—liver—malaria	0.000243	0.000769	CbGeAlD
Bosutinib—SRC—brain—malaria	0.000243	0.000767	CbGeAlD
Bosutinib—ABCB1—blood plasma—malaria	0.000236	0.000744	CbGeAlD
Bosutinib—MAP2K5—brain—malaria	0.000223	0.000705	CbGeAlD
Bosutinib—CSF1R—brain—malaria	0.000218	0.000688	CbGeAlD
Bosutinib—ABL1—liver—malaria	0.000217	0.000686	CbGeAlD
Bosutinib—PDGFRB—brain—malaria	0.000193	0.000611	CbGeAlD
Bosutinib—CYP3A4—hematopoietic system—malaria	0.000184	0.000581	CbGeAlD
Bosutinib—ABL1—brain—malaria	0.000172	0.000544	CbGeAlD
Bosutinib—CYP3A4—kidney—malaria	0.000151	0.000477	CbGeAlD
Bosutinib—ABCB1—hematopoietic system—malaria	0.00013	0.000412	CbGeAlD
Bosutinib—CYP3A4—digestive system—malaria	0.000128	0.000404	CbGeAlD
Bosutinib—CYP3A4—blood—malaria	0.000122	0.000385	CbGeAlD
Bosutinib—ABCB1—kidney—malaria	0.000107	0.000337	CbGeAlD
Bosutinib—CYP3A4—liver—malaria	9.53e-05	0.000301	CbGeAlD
Bosutinib—ABCB1—digestive system—malaria	9.06e-05	0.000286	CbGeAlD
Bosutinib—ABCB1—blood—malaria	8.63e-05	0.000273	CbGeAlD
Bosutinib—ABCB1—bone marrow—malaria	8.35e-05	0.000264	CbGeAlD
Bosutinib—ABCB1—liver—malaria	6.75e-05	0.000213	CbGeAlD
Bosutinib—ABCB1—brain—malaria	5.35e-05	0.000169	CbGeAlD
Bosutinib—FYN—Immune System—TLR4—malaria	1.12e-05	3.55e-05	CbGpPWpGaD
Bosutinib—EGFR—Immune System—CD36—malaria	1.12e-05	3.55e-05	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—PKLR—malaria	1.11e-05	3.54e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—TLR4—malaria	1.11e-05	3.53e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—ICAM1—malaria	1.11e-05	3.53e-05	CbGpPWpGaD
Bosutinib—YES1—Immune System—IFNG—malaria	1.11e-05	3.53e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling by NGF—IL6—malaria	1.11e-05	3.52e-05	CbGpPWpGaD
Bosutinib—LCK—Immune System—HLA-B—malaria	1.1e-05	3.49e-05	CbGpPWpGaD
Bosutinib—FER—Signaling Pathways—IL6—malaria	1.1e-05	3.49e-05	CbGpPWpGaD
Bosutinib—SYK—Immune System—IL6—malaria	1.09e-05	3.48e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Developmental Biology—TNF—malaria	1.09e-05	3.47e-05	CbGpPWpGaD
Bosutinib—LYN—Immune System—ICAM1—malaria	1.09e-05	3.46e-05	CbGpPWpGaD
Bosutinib—PTK2—Immune System—CD4—malaria	1.09e-05	3.46e-05	CbGpPWpGaD
Bosutinib—LCK—Cytokine Signaling in Immune system—IL6—malaria	1.09e-05	3.45e-05	CbGpPWpGaD
Bosutinib—ABL1—Immune System—ICAM1—malaria	1.08e-05	3.44e-05	CbGpPWpGaD
Bosutinib—LCK—Adaptive Immune System—CD4—malaria	1.08e-05	3.43e-05	CbGpPWpGaD
Bosutinib—LCK—Immune System—CD36—malaria	1.08e-05	3.42e-05	CbGpPWpGaD
Bosutinib—PRKCQ—Immune System—IL6—malaria	1.07e-05	3.41e-05	CbGpPWpGaD
Bosutinib—YES1—Immune System—CD4—malaria	1.07e-05	3.41e-05	CbGpPWpGaD
Bosutinib—FYN—Immune System—ICAM1—malaria	1.07e-05	3.4e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling by NGF—IL6—malaria	1.07e-05	3.39e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—ICAM1—malaria	1.07e-05	3.39e-05	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—DHODH—malaria	1.07e-05	3.38e-05	CbGpPWpGaD
Bosutinib—IRAK1—Immune System—IFNG—malaria	1.05e-05	3.35e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—NOS2—malaria	1.04e-05	3.32e-05	CbGpPWpGaD
Bosutinib—LYN—Developmental Biology—TNF—malaria	1.04e-05	3.31e-05	CbGpPWpGaD
Bosutinib—AXL—Signaling Pathways—IL6—malaria	1.04e-05	3.31e-05	CbGpPWpGaD
Bosutinib—ABL1—Developmental Biology—TNF—malaria	1.04e-05	3.3e-05	CbGpPWpGaD
Bosutinib—CSK—Immune System—IL6—malaria	1.04e-05	3.29e-05	CbGpPWpGaD
Bosutinib—FYN—Developmental Biology—TNF—malaria	1.03e-05	3.26e-05	CbGpPWpGaD
Bosutinib—SRC—Immune System—IL18—malaria	1.03e-05	3.26e-05	CbGpPWpGaD
Bosutinib—SRC—Immune System—CD40LG—malaria	1.02e-05	3.25e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Developmental Biology—TNF—malaria	1.02e-05	3.24e-05	CbGpPWpGaD
Bosutinib—SRC—Hemostasis—IL2—malaria	1.02e-05	3.24e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—NOS2—malaria	1.02e-05	3.24e-05	CbGpPWpGaD
Bosutinib—IRAK1—Immune System—CD4—malaria	1.02e-05	3.23e-05	CbGpPWpGaD
Bosutinib—SRC—Immune System—CD8A—malaria	1.01e-05	3.21e-05	CbGpPWpGaD
Bosutinib—PTK2—Innate Immune System—IL6—malaria	1.01e-05	3.21e-05	CbGpPWpGaD
Bosutinib—EGFR—Immune System—CRP—malaria	1.01e-05	3.2e-05	CbGpPWpGaD
Bosutinib—PTK2—Immune System—IL1B—malaria	1.01e-05	3.19e-05	CbGpPWpGaD
Bosutinib—EGFR—Axon guidance—IL6—malaria	1e-05	3.18e-05	CbGpPWpGaD
Bosutinib—PTK2—Immune System—IL2—malaria	1e-05	3.18e-05	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—KDR—malaria	9.99e-06	3.17e-05	CbGpPWpGaD
Bosutinib—SRC—Innate Immune System—CD4—malaria	9.98e-06	3.17e-05	CbGpPWpGaD
Bosutinib—YES1—Innate Immune System—IL6—malaria	9.97e-06	3.16e-05	CbGpPWpGaD
Bosutinib—BMPR2—Signaling Pathways—IL6—malaria	9.94e-06	3.15e-05	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—G6PD—malaria	9.93e-06	3.15e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Immune System—IFNG—malaria	9.93e-06	3.15e-05	CbGpPWpGaD
Bosutinib—PRKCQ—Disease—IL6—malaria	9.92e-06	3.15e-05	CbGpPWpGaD
Bosutinib—CSNK1A1—Disease—IL6—malaria	9.92e-06	3.15e-05	CbGpPWpGaD
Bosutinib—YES1—Immune System—IL1B—malaria	9.92e-06	3.15e-05	CbGpPWpGaD
Bosutinib—YES1—Immune System—IL2—malaria	9.88e-06	3.14e-05	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—KDR—malaria	9.85e-06	3.13e-05	CbGpPWpGaD
Bosutinib—FYN—Disease—NOS2—malaria	9.83e-06	3.12e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—NOS2—malaria	9.77e-06	3.1e-05	CbGpPWpGaD
Bosutinib—SRC—Immune System—HLA-B—malaria	9.73e-06	3.09e-05	CbGpPWpGaD
Bosutinib—LCK—Immune System—CRP—malaria	9.72e-06	3.08e-05	CbGpPWpGaD
Bosutinib—EGFR—Immune System—TLR4—malaria	9.67e-06	3.07e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Immune System—CD4—malaria	9.59e-06	3.04e-05	CbGpPWpGaD
Bosutinib—CSK—Disease—IL6—malaria	9.58e-06	3.04e-05	CbGpPWpGaD
Bosutinib—SRC—Adaptive Immune System—CD4—malaria	9.58e-06	3.04e-05	CbGpPWpGaD
Bosutinib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malaria	9.58e-06	3.04e-05	CbGpPWpGaD
Bosutinib—CSNK1E—Signaling Pathways—IL2—malaria	9.55e-06	3.03e-05	CbGpPWpGaD
Bosutinib—SRC—Immune System—CD36—malaria	9.54e-06	3.03e-05	CbGpPWpGaD
Bosutinib—BCR—Signaling Pathways—IL6—malaria	9.53e-06	3.02e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling by NGF—IL6—malaria	9.46e-06	3e-05	CbGpPWpGaD
Bosutinib—IRAK1—Innate Immune System—IL6—malaria	9.46e-06	3e-05	CbGpPWpGaD
Bosutinib—IRAK1—Immune System—IL1B—malaria	9.41e-06	2.99e-05	CbGpPWpGaD
Bosutinib—IRAK1—Immune System—IL2—malaria	9.37e-06	2.97e-05	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—KDR—malaria	9.35e-06	2.97e-05	CbGpPWpGaD
Bosutinib—LCK—Immune System—TLR4—malaria	9.32e-06	2.96e-05	CbGpPWpGaD
Bosutinib—TBK1—Immune System—IL6—malaria	9.31e-06	2.96e-05	CbGpPWpGaD
Bosutinib—EGFR—Immune System—ICAM1—malaria	9.27e-06	2.94e-05	CbGpPWpGaD
Bosutinib—CAMK2G—Immune System—IL6—malaria	9.14e-06	2.9e-05	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—SLC4A1—malaria	9.06e-06	2.88e-05	CbGpPWpGaD
Bosutinib—LCK—Immune System—ICAM1—malaria	8.93e-06	2.83e-05	CbGpPWpGaD
Bosutinib—MAP3K3—Immune System—IL6—malaria	8.93e-06	2.83e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Innate Immune System—IL6—malaria	8.9e-06	2.83e-05	CbGpPWpGaD
Bosutinib—EGFR—Developmental Biology—TNF—malaria	8.87e-06	2.82e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Immune System—IL1B—malaria	8.86e-06	2.81e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Immune System—IL2—malaria	8.82e-06	2.8e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Developmental Biology—IL6—malaria	8.81e-06	2.8e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—KDR—malaria	8.8e-06	2.79e-05	CbGpPWpGaD
Bosutinib—BTK—Immune System—IL6—malaria	8.68e-06	2.76e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Immune System—IFNG—malaria	8.68e-06	2.75e-05	CbGpPWpGaD
Bosutinib—SRC—Immune System—CRP—malaria	8.6e-06	2.73e-05	CbGpPWpGaD
Bosutinib—SRC—Axon guidance—IL6—malaria	8.56e-06	2.72e-05	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—DECR1—malaria	8.52e-06	2.7e-05	CbGpPWpGaD
Bosutinib—EGFR—Disease—NOS2—malaria	8.49e-06	2.69e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—IFNG—malaria	8.47e-06	2.69e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling by GPCR—IL2—malaria	8.44e-06	2.68e-05	CbGpPWpGaD
Bosutinib—LYN—Developmental Biology—IL6—malaria	8.42e-06	2.67e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Immune System—CD4—malaria	8.38e-06	2.66e-05	CbGpPWpGaD
Bosutinib—ABL1—Developmental Biology—IL6—malaria	8.38e-06	2.66e-05	CbGpPWpGaD
Bosutinib—FES—Signaling Pathways—IL6—malaria	8.33e-06	2.64e-05	CbGpPWpGaD
Bosutinib—IRAK4—Immune System—IL6—malaria	8.3e-06	2.63e-05	CbGpPWpGaD
Bosutinib—LYN—Immune System—IFNG—malaria	8.29e-06	2.63e-05	CbGpPWpGaD
Bosutinib—FYN—Developmental Biology—IL6—malaria	8.29e-06	2.63e-05	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—IL2—malaria	8.26e-06	2.62e-05	CbGpPWpGaD
Bosutinib—ABL1—Immune System—IFNG—malaria	8.25e-06	2.62e-05	CbGpPWpGaD
Bosutinib—SRC—Immune System—TLR4—malaria	8.25e-06	2.62e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Developmental Biology—IL6—malaria	8.24e-06	2.62e-05	CbGpPWpGaD
Bosutinib—LCK—Disease—NOS2—malaria	8.18e-06	2.6e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—CD4—malaria	8.18e-06	2.6e-05	CbGpPWpGaD
Bosutinib—FYN—Immune System—IFNG—malaria	8.16e-06	2.59e-05	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—IL2—malaria	8.14e-06	2.58e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—IFNG—malaria	8.12e-06	2.58e-05	CbGpPWpGaD
Bosutinib—CSNK1E—Disease—IL6—malaria	8.02e-06	2.54e-05	CbGpPWpGaD
Bosutinib—LYN—Immune System—CD4—malaria	8.01e-06	2.54e-05	CbGpPWpGaD
Bosutinib—ABL1—Immune System—CD4—malaria	7.97e-06	2.53e-05	CbGpPWpGaD
Bosutinib—HCK—Immune System—IL6—malaria	7.97e-06	2.53e-05	CbGpPWpGaD
Bosutinib—SRC—Immune System—ICAM1—malaria	7.91e-06	2.51e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling by GPCR—IL2—malaria	7.9e-06	2.51e-05	CbGpPWpGaD
Bosutinib—FYN—Immune System—CD4—malaria	7.88e-06	2.5e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—CD4—malaria	7.84e-06	2.49e-05	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—IL2—malaria	7.84e-06	2.49e-05	CbGpPWpGaD
Bosutinib—ROCK1—Signaling by GPCR—IL6—malaria	7.8e-06	2.47e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Innate Immune System—IL6—malaria	7.78e-06	2.47e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Immune System—IL1B—malaria	7.74e-06	2.46e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—CD4—malaria	7.74e-06	2.46e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Immune System—IL2—malaria	7.71e-06	2.45e-05	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—HBB—malaria	7.7e-06	2.45e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—KDR—malaria	7.69e-06	2.44e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Innate Immune System—IL6—malaria	7.59e-06	2.41e-05	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—HPGDS—malaria	7.58e-06	2.4e-05	CbGpPWpGaD
Bosutinib—SRC—Developmental Biology—TNF—malaria	7.57e-06	2.4e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—IL1B—malaria	7.55e-06	2.4e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—CD4—malaria	7.55e-06	2.4e-05	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—IL2—malaria	7.55e-06	2.4e-05	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—IL2—malaria	7.55e-06	2.4e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—IL2—malaria	7.53e-06	2.39e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—KDR—malaria	7.51e-06	2.38e-05	CbGpPWpGaD
Bosutinib—ERBB4—Immune System—IL6—malaria	7.5e-06	2.38e-05	CbGpPWpGaD
Bosutinib—LYN—Innate Immune System—IL6—malaria	7.44e-06	2.36e-05	CbGpPWpGaD
Bosutinib—ABL1—Innate Immune System—IL6—malaria	7.4e-06	2.35e-05	CbGpPWpGaD
Bosutinib—PTK2B—Immune System—IL6—malaria	7.4e-06	2.35e-05	CbGpPWpGaD
Bosutinib—LYN—Immune System—IL1B—malaria	7.4e-06	2.35e-05	CbGpPWpGaD
Bosutinib—LYN—Immune System—IL2—malaria	7.37e-06	2.34e-05	CbGpPWpGaD
Bosutinib—ABL1—Immune System—IL1B—malaria	7.36e-06	2.34e-05	CbGpPWpGaD
Bosutinib—HCK—Disease—IL6—malaria	7.36e-06	2.33e-05	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—KDR—malaria	7.35e-06	2.33e-05	CbGpPWpGaD
Bosutinib—ABL1—Immune System—IL2—malaria	7.33e-06	2.33e-05	CbGpPWpGaD
Bosutinib—FYN—Innate Immune System—IL6—malaria	7.32e-06	2.32e-05	CbGpPWpGaD
Bosutinib—FYN—Immune System—IL1B—malaria	7.28e-06	2.31e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Innate Immune System—IL6—malaria	7.28e-06	2.31e-05	CbGpPWpGaD
Bosutinib—FYN—Disease—CD4—malaria	7.28e-06	2.31e-05	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—IL2—malaria	7.28e-06	2.31e-05	CbGpPWpGaD
Bosutinib—FYN—Immune System—IL2—malaria	7.25e-06	2.3e-05	CbGpPWpGaD
Bosutinib—SRC—Disease—NOS2—malaria	7.24e-06	2.3e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—IL1B—malaria	7.24e-06	2.3e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—CD4—malaria	7.24e-06	2.3e-05	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—KDR—malaria	7.23e-06	2.3e-05	CbGpPWpGaD
Bosutinib—BLK—Immune System—IL6—malaria	7.22e-06	2.29e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—IL2—malaria	7.21e-06	2.29e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—KDR—malaria	7.2e-06	2.28e-05	CbGpPWpGaD
Bosutinib—FGR—Immune System—IL6—malaria	7.2e-06	2.28e-05	CbGpPWpGaD
Bosutinib—EGFR—Developmental Biology—IL6—malaria	7.16e-06	2.27e-05	CbGpPWpGaD
Bosutinib—SYK—Signaling Pathways—IL6—malaria	7.08e-06	2.25e-05	CbGpPWpGaD
Bosutinib—EGFR—Immune System—IFNG—malaria	7.05e-06	2.24e-05	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—DHFR—malaria	7.03e-06	2.23e-05	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—SCARB1—malaria	6.96e-06	2.21e-05	CbGpPWpGaD
Bosutinib—PRKCQ—Signaling Pathways—IL6—malaria	6.95e-06	2.21e-05	CbGpPWpGaD
Bosutinib—CSNK1A1—Signaling Pathways—IL6—malaria	6.95e-06	2.21e-05	CbGpPWpGaD
Bosutinib—ERBB4—Disease—IL6—malaria	6.93e-06	2.2e-05	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—PKLR—malaria	6.87e-06	2.18e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling by GPCR—IL2—malaria	6.86e-06	2.18e-05	CbGpPWpGaD
Bosutinib—EGFR—Immune System—CD4—malaria	6.81e-06	2.16e-05	CbGpPWpGaD
Bosutinib—LCK—Immune System—IFNG—malaria	6.8e-06	2.16e-05	CbGpPWpGaD
Bosutinib—CSK—Signaling Pathways—IL6—malaria	6.71e-06	2.13e-05	CbGpPWpGaD
Bosutinib—ERBB3—Immune System—IL6—malaria	6.62e-06	2.1e-05	CbGpPWpGaD
Bosutinib—LCK—Immune System—CD4—malaria	6.56e-06	2.08e-05	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—IL2—malaria	6.48e-06	2.06e-05	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—IL2—malaria	6.39e-06	2.03e-05	CbGpPWpGaD
Bosutinib—EGFR—Innate Immune System—IL6—malaria	6.32e-06	2.01e-05	CbGpPWpGaD
Bosutinib—EGFR—Immune System—IL1B—malaria	6.29e-06	2e-05	CbGpPWpGaD
Bosutinib—EGFR—Disease—CD4—malaria	6.29e-06	2e-05	CbGpPWpGaD
Bosutinib—EGFR—Immune System—IL2—malaria	6.27e-06	1.99e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—KDR—malaria	6.25e-06	1.98e-05	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—G6PD—malaria	6.12e-06	1.94e-05	CbGpPWpGaD
Bosutinib—SRC—Developmental Biology—IL6—malaria	6.11e-06	1.94e-05	CbGpPWpGaD
Bosutinib—ERBB3—Disease—IL6—malaria	6.11e-06	1.94e-05	CbGpPWpGaD
Bosutinib—LCK—Innate Immune System—IL6—malaria	6.09e-06	1.93e-05	CbGpPWpGaD
Bosutinib—LCK—Immune System—IL1B—malaria	6.06e-06	1.92e-05	CbGpPWpGaD
Bosutinib—LCK—Disease—CD4—malaria	6.06e-06	1.92e-05	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—IL2—malaria	6.06e-06	1.92e-05	CbGpPWpGaD
Bosutinib—LCK—Immune System—IL2—malaria	6.04e-06	1.92e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—KDR—malaria	6.02e-06	1.91e-05	CbGpPWpGaD
Bosutinib—SRC—Immune System—IFNG—malaria	6.02e-06	1.91e-05	CbGpPWpGaD
Bosutinib—PTK2—Immune System—IL6—malaria	5.89e-06	1.87e-05	CbGpPWpGaD
Bosutinib—SRC—Immune System—CD4—malaria	5.81e-06	1.84e-05	CbGpPWpGaD
Bosutinib—YES1—Immune System—IL6—malaria	5.81e-06	1.84e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—IL2—malaria	5.71e-06	1.81e-05	CbGpPWpGaD
Bosutinib—CSNK1E—Signaling Pathways—IL6—malaria	5.61e-06	1.78e-05	CbGpPWpGaD
Bosutinib—IRAK1—Immune System—IL6—malaria	5.51e-06	1.75e-05	CbGpPWpGaD
Bosutinib—SRC—Innate Immune System—IL6—malaria	5.4e-06	1.71e-05	CbGpPWpGaD
Bosutinib—SRC—Immune System—IL1B—malaria	5.37e-06	1.7e-05	CbGpPWpGaD
Bosutinib—SRC—Disease—CD4—malaria	5.36e-06	1.7e-05	CbGpPWpGaD
Bosutinib—SRC—Immune System—IL2—malaria	5.35e-06	1.7e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—KDR—malaria	5.33e-06	1.69e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Immune System—IL6—malaria	5.19e-06	1.65e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—IL2—malaria	4.99e-06	1.58e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling by GPCR—IL6—malaria	4.96e-06	1.57e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—IL2—malaria	4.87e-06	1.54e-05	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—IL6—malaria	4.85e-06	1.54e-05	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—IL6—malaria	4.78e-06	1.52e-05	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—IL2—malaria	4.76e-06	1.51e-05	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—IL2—malaria	4.69e-06	1.49e-05	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—HPGDS—malaria	4.67e-06	1.48e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—IL2—malaria	4.66e-06	1.48e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling by GPCR—IL6—malaria	4.64e-06	1.47e-05	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—IL6—malaria	4.61e-06	1.46e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Immune System—IL6—malaria	4.53e-06	1.44e-05	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—IL6—malaria	4.44e-06	1.41e-05	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—IL6—malaria	4.44e-06	1.41e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—IL6—malaria	4.42e-06	1.4e-05	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—CD36—malaria	4.37e-06	1.39e-05	CbGpPWpGaD
Bosutinib—LYN—Immune System—IL6—malaria	4.33e-06	1.37e-05	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—DHFR—malaria	4.33e-06	1.37e-05	CbGpPWpGaD
Bosutinib—ABL1—Immune System—IL6—malaria	4.31e-06	1.37e-05	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—SCARB1—malaria	4.29e-06	1.36e-05	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—IL6—malaria	4.28e-06	1.36e-05	CbGpPWpGaD
Bosutinib—FYN—Immune System—IL6—malaria	4.26e-06	1.35e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—IL6—malaria	4.24e-06	1.35e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—IL6—malaria	4.18e-06	1.33e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—IL6—malaria	4.08e-06	1.3e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—IL2—malaria	4.05e-06	1.29e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling by GPCR—IL6—malaria	4.03e-06	1.28e-05	CbGpPWpGaD
Bosutinib—FYN—Disease—IL6—malaria	3.94e-06	1.25e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—IL6—malaria	3.92e-06	1.24e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—IL2—malaria	3.9e-06	1.24e-05	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—IL6—malaria	3.81e-06	1.21e-05	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—IL6—malaria	3.75e-06	1.19e-05	CbGpPWpGaD
Bosutinib—EGFR—Immune System—IL6—malaria	3.68e-06	1.17e-05	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—IL6—malaria	3.56e-06	1.13e-05	CbGpPWpGaD
Bosutinib—LCK—Immune System—IL6—malaria	3.55e-06	1.13e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—IL2—malaria	3.46e-06	1.1e-05	CbGpPWpGaD
Bosutinib—EGFR—Disease—IL6—malaria	3.4e-06	1.08e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—IL6—malaria	3.35e-06	1.06e-05	CbGpPWpGaD
Bosutinib—LCK—Disease—IL6—malaria	3.28e-06	1.04e-05	CbGpPWpGaD
Bosutinib—SRC—Immune System—IL6—malaria	3.14e-06	9.97e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—IL6—malaria	2.93e-06	9.3e-06	CbGpPWpGaD
Bosutinib—SRC—Disease—IL6—malaria	2.9e-06	9.21e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—IL6—malaria	2.86e-06	9.08e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—IL6—malaria	2.8e-06	8.89e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—IL6—malaria	2.76e-06	8.75e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—IL6—malaria	2.74e-06	8.7e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—CD36—malaria	2.69e-06	8.54e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—IL6—malaria	2.38e-06	7.56e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—IL6—malaria	2.29e-06	7.28e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—IL6—malaria	2.03e-06	6.45e-06	CbGpPWpGaD
